Viatris (VTRS) EPS (Diluted) Growth (1y) (2020 - 2026)
Viatris (VTRS) EPS (Diluted) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 65.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 5.88% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -394.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.15% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 105.88% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,383.26% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -16.09% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -257.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.88% |
| Dec 31, 2025 | 32.88% |
| Sep 30, 2025 | -239.39% |
| Jun 30, 2025 | 98.57% |
| Mar 31, 2025 | -2,809.06% |
| Dec 31, 2024 | 31.77% |
| Sep 30, 2024 | -71.24% |
| Jun 30, 2024 | -224.92% |
| Mar 31, 2024 | -49.47% |
| Dec 31, 2023 | -176.37% |
| Sep 30, 2023 | -5.59% |
| Jun 30, 2023 | -14.95% |
| Mar 31, 2023 | -43.36% |
| Dec 31, 2022 | 480.61% |
| Sep 30, 2022 | 13.23% |
| Jun 30, 2022 | 211.66% |
| Mar 31, 2022 | 138.30% |
| Dec 31, 2021 | 85.67% |
| Sep 30, 2021 | 178.62% |
| Jun 30, 2021 | -13,168.11% |